ID24264A - COMPOSITION CONSIST OF 5- [4- [2- (N-METHYL-N-2-PYRIDYL) AMINO) ETHOCYSIE [BENZIL] TIAZOLIDIN-2,4-DION - Google Patents

COMPOSITION CONSIST OF 5- [4- [2- (N-METHYL-N-2-PYRIDYL) AMINO) ETHOCYSIE [BENZIL] TIAZOLIDIN-2,4-DION

Info

Publication number: ID24264A
Authority: ID; Indonesia
Prior art keywords: ethocysie; tiazolidin; dion; benzil; pyridyl
Prior art date: 1997-06-05

Application number

IDW991520A

Other languages

Indonesian (id)

Inventor

Jeffrey Roger Granett

Original Assignee

Smithkline Beecham P L C Cs

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-02

Publication date

2000-07-13

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1998-06-02 Application filed by Smithkline Beecham P L C Cs filed Critical Smithkline Beecham P L C Cs

2000-07-13 Publication of ID24264A publication Critical patent/ID24264A/en

Links

-1 AMINO Chemical class 0.000 title 1
229920004518 DION® Polymers 0.000 title 1
WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

IDW991520A 1997-06-05 1998-06-02 COMPOSITION CONSIST OF 5- [4- [2- (N-METHYL-N-2-PYRIDYL) AMINO) ETHOCYSIE [BENZIL] TIAZOLIDIN-2,4-DION ID24264A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition
PCT/EP1998/003478 WO1998055122A1 (en)	1997-06-05	1998-06-02	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number	Publication Date
ID24264A true ID24264A (en)	2000-07-13

Family

ID=26311662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW991520A ID24264A (en)	1997-06-05	1998-06-02	COMPOSITION CONSIST OF 5- [4- [2- (N-METHYL-N-2-PYRIDYL) AMINO) ETHOCYSIE [BENZIL] TIAZOLIDIN-2,4-DION

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (en)
JP (1)	JP2001521553A (en)
KR (1)	KR20010013410A (en)
CN (3)	CN1112926C (en)
AP (1)	AP1214A (en)
AR (2)	AR008198A1 (en)
AU (1)	AU8215098A (en)
BG (1)	BG104048A (en)
BR (1)	BR9810405A (en)
CA (2)	CA2333352A1 (en)
CO (1)	CO4940400A1 (en)
DZ (1)	DZ2510A1 (en)
EA (1)	EA002384B1 (en)
GB (1)	GB9711683D0 (en)
HU (1)	HUP0004070A3 (en)
ID (1)	ID24264A (en)
IL (1)	IL133074A0 (en)
MX (1)	MXPA99011322A (en)
NO (2)	NO995938L (en)
NZ (2)	NZ523725A (en)
OA (1)	OA11306A (en)
PE (1)	PE78899A1 (en)
PL (1)	PL337201A1 (en)
SK (1)	SK164899A3 (en)
TR (2)	TR200002790T2 (en)
TW (1)	TW570797B (en)
UY (1)	UY25032A1 (en)
WO (1)	WO1998055122A1 (en)
ZA (2)	ZA984826B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
AR023561A1 (en) *	1999-04-23	2002-09-04	Smithkline Beecham Corp	A POLYMORPHIC FORM OF THE MALEIC ACID OF A DERIVATIVE OF TIAZOLIDIN-2, 4 DIONA, A PHARMACEUTICAL COMPOSITION AND THE USE OF SUCH POLYMORPH FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
HRP20010773B1 (en)	1999-04-23	2005-06-30	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
WO2003050112A1 (en) *	2001-12-13	2003-06-19	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
ES2294980T1 (en) *	2006-05-09	2008-04-16	Teva Pharmaceutical Industries Ltd.	ACID 2-N- (5 - ((4- (2- (METHYL-2-PYRIDINYLAMINE) ETHOXY) PHENYL) METHYL) -2,4-THIAZOLIDINDIONA) -BUTANODIOIC, PREPARATION PROCEDURES AND COMPOSITIONS WITH ROSIGLITAZONA MALEATE.
WO2015008234A1 (en) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE186724T1 (en) *	1987-09-04	1999-12-15	Beecham Group Plc	SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVES
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
WO1995021608A1 (en) *	1994-02-10	1995-08-17	Smithkline Beecham Plc	Use of insulin sensitisers for treating renal diseases
JPH11510508A (en) *	1995-08-10	1999-09-14	ワーナー−ランバート・コンパニー	Methods for reducing the amount of exogenous insulin administered to non-insulin dependent diabetes mellitus patients
WO1997018811A1 (en) *	1995-11-17	1997-05-29	Warner-Lambert Company	A method of treating myotonic dystrophy
NZ314406A (en) *	1996-03-18	2000-12-22	Sankyo Co	Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
AU3552697A (en) *	1996-07-12	1998-02-09	Smithkline Beecham Plc	Novel treatment of leptine resistance

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 SK SK1648-99A patent/SK164899A3/en unknown
- 1998-06-02 CA CA002333352A patent/CA2333352A1/en not_active Abandoned
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/en not_active IP Right Cessation
- 1998-06-02 PL PL98337201A patent/PL337201A1/en unknown
- 1998-06-02 CA CA002292629A patent/CA2292629C/en not_active Expired - Fee Related
- 1998-06-02 EA EA199901116A patent/EA002384B1/en not_active IP Right Cessation
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/en not_active Ceased
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/en unknown
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/en not_active Ceased
- 1998-06-02 EP EP98932144A patent/EP0998284A1/en not_active Withdrawn
- 1998-06-02 JP JP50158799A patent/JP2001521553A/en not_active Ceased
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/en unknown
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/en unknown
- 1998-06-02 IL IL13307498A patent/IL133074A0/en unknown
- 1998-06-02 CN CN98805686A patent/CN1112926C/en not_active Expired - Lifetime
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/en active Pending
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/en unknown
- 1998-06-02 ID IDW991520A patent/ID24264A/en unknown
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/en active
- 1998-06-04 AR ARP980102649A patent/AR008198A1/en not_active Application Discontinuation
- 1998-06-04 AR ARP980102650A patent/AR015120A1/en not_active Application Discontinuation
- 1998-06-04 CO CO98031614A patent/CO4940400A1/en unknown
- 1998-06-04 UY UY25032A patent/UY25032A1/en not_active IP Right Cessation
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/en unknown
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/en unknown
- 1998-06-05 PE PE1998000466A patent/PE78899A1/en not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/en not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/en not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/en unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/en unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/en active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2292629C (en)	2004-01-06
MXPA99011322A (en)	2004-12-02
BG104048A (en)	2000-07-31
EA002384B1 (en)	2002-04-25
NO20040738L (en)	2000-02-02
EA199901116A1 (en)	2000-06-26
NO995938D0 (en)	1999-12-03
NO995938L (en)	2000-02-02
AR015120A1 (en)	2001-04-18
NZ513922A (en)	2001-09-28
AR008198A1 (en)	1999-12-29
TW570797B (en)	2004-01-11
AU8215098A (en)	1998-12-21
WO1998055122A1 (en)	1998-12-10
BR9810405A (en)	2000-08-29
JP2001521553A (en)	2001-11-06
KR20010013410A (en)	2001-02-26
CN1259050A (en)	2000-07-05
NZ523725A (en)	2004-09-24
HUP0004070A2 (en)	2002-02-28
CA2292629A1 (en)	1998-12-10
CN1526391A (en)	2004-09-08
PL337201A1 (en)	2000-08-14
CA2333352A1 (en)	1998-12-10
GB9711683D0 (en)	1997-08-06
CN1112926C (en)	2003-07-02
ZA984826B (en)	1999-08-03
TR200002790T2 (en)	2001-11-21
CO4940400A1 (en)	2000-07-24
HUP0004070A3 (en)	2002-03-28
IL133074A0 (en)	2001-03-19
TR199902963T2 (en)	2000-02-21
DZ2510A1 (en)	2003-01-25
PE78899A1 (en)	1999-10-22
OA11306A (en)	2003-10-22
ZA9811572B (en)	1999-07-22
CN1430959A (en)	2003-07-23
AP1214A (en)	2003-10-08
SK164899A3 (en)	2000-11-07
AP9901696A0 (en)	1999-12-31
EP0998284A1 (en)	2000-05-10
UY25032A1 (en)	1998-11-26

Publication	Publication Date	Title
DE69718480D1 (en)	2003-02-20	HETEROCYCLIC METALLOPROTEASE INHIBITORS
ATE226573T1 (en)	2002-11-15	HETEROCYCLIC METALLOPROTEASE INHIBITORS
ATE267805T1 (en)	2004-06-15	LACTAM COMPOUNDS AS METALLOPROTEASE INHIBITORS
ATE443055T1 (en)	2009-10-15	TYPE 1 11-BETA-HYDROXY-STEROID DEHYDROGENASE INHIBITORS
ATE417828T1 (en)	2009-01-15	HETEROCYCLIC INHIBITORS OF P38
NO20021116D0 (en)	2002-03-06	New composition
DE69830410D1 (en)	2005-07-07	META BENZAMIDINE DERIVATIVES AS SERINE PROTEASE INHIBITORS
DK1114051T3 (en)	2003-07-14	Inhibitors of p38
MA26500A1 (en)	2004-12-20	NEW FORM OF S-OMERPRAZOLE
NO990548L (en)	1999-04-07	Inhibitors of cysteine protease
NO20020307D0 (en)	2002-01-21	N- (indolecarbonyl) piperazine
NO20021115L (en)	2002-04-30	New composition
DE60009675D1 (en)	2004-05-13	COMPOSITION CONTAINING PROTON PUMP INHIBITORS
ATE333866T1 (en)	2006-08-15	DISPERSION FORMULATIONS CONTAINING LIPASE INHIBITORS
DK0928291T3 (en)	2003-03-17	3-Mercaptoacetylamino-1,5-substituted 2-oxo-azepane derivatives useful as inhibitors of matrix metalloproteinase
AP9901696A0 (en)	1999-12-31	Composition comprising 5-(4-(2-(N-methyl-N-2-pyridyl)amino) ehtoxy benzyl)thiazolidine-2,4-dione
ID24267A (en)	2000-07-13	ENANSIOMERS OF 4 - [[(SIANOIMINO) [(1,2,2-TRIMETHYLOPOPIL) AMINO] METHYL] AMINO] BENZONITRIL
DK199901730A (en)	2000-12-23	New Composition
DK0928192T3 (en)	2002-08-19	High-release active substance antimycotic gel
BR9710322A (en)	1999-08-17	Substituted N- (5-isothiazolyl) thioamides
DK0888340T3 (en)	2002-11-04	4- (Benzo-1,3-dioxolyl) -pyrrolidine-3-carboxylic acid derivatives as antagonists of enodthelin
ATE525362T1 (en)	2011-10-15	2-(3-(4-(2-T-BUTYL-6-TRIFLUORMETHYLPYRIMIDINE-4-
ID24081A (en)	2000-07-06	COMPOUNDS 5- (2-IMIDAZOLINILAMINO) BENZIMIDAZOL USING AS ALFA-2-ADRENOSEPTOR AGONISTS
DK0944601T3 (en)	2003-06-10	Heterocyclic quanidinylamino compounds as alpha-2-adrenoceptor agonists
DK1150976T3 (en)	2003-06-02	3- (Thiosubstituted amido) lactams useful as inhibitors of matrix metalloproteinase